{"nct_id":"NCT03853317","title":"QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy","status":"TERMINATED","status_verified_date":"2024-08","start_date":"2020-02-19","start_date_type":"ACTUAL","primary_completion_date":"2021-09-29","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["IBRX"]}